In the BioHarmony Drug Report Database
Cedilanid-d (deslanoside) is a small molecule pharmaceutical. Deslanoside was first approved as Cedilanid-d on 1982-01-01. It is used to treat atrial fibrillation, atrial flutter, heart failure, low cardiac output, and supraventricular tachycardia in the USA. The pharmaceutical is active against sodium/potassium-transporting ATPase subunit alpha-1.
Image (chem structure or protein)